Search | IOVS | ARVO Journals

Showing 1 – 20 of 46

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2023

LP-ACE2 attenuates diabetic visual impairment by improving gut barrier integrity and intestinal lymphatics in type 1 diabetes

Ram Prasad; Jason Floyd; Yvonne Adu-Agyeiwaah; Bright Asare-Bediako; Sergio Li Calzi; Dibyendu Chakraborty; Angela Harbour; Aayush Rohella; Irina A Pikuleva; Julia V. Busik; Qiuhong Li; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):938.

ARVO Annual Meeting Abstract June 2023

Human iPSC derived CD34 + cells and endothelial colony-forming cells (ECFCs) correct diabetic retinopathy (DR) in a model of type 2 diabetes

Yazen Shihab; Sergio Li Calzi; Yvonne Adu-Agyeiwaah; Cristiano Vieira; Michael E. Boulton; Carolina Francelin Rovarotto; Matt George; Dave Mann; Mervin C. Yoder; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1307.

ARVO Annual Meeting Abstract June 2023

Oral alpha-cyclodextrin reverses cholesterol-crystal-induced retinal pathology in a rodent model of type 2 diabetes (T2D).

Yvonne Adu-Agyeiwaah; Bright Asare-Bediako; Jason Floyd; Mariana D DuPont; Cristiano Vieira; Ram Prasad; Sergio Li Calzi; Irina A Pikuleva; Julia V. Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1834.

ARVO Annual Meeting Abstract June 2023

Calvarium bone marrow is the source of bone marrow-derived cells that migrate into the injured retina

Sergio Li Calzi; Bright Asare-Bediako; Yvonne Adu-Agyeiwaah; Ram Prasad; Julia V. Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3866.

Retina April 2023

Intravitreal Administration of AAV2-SIRT1 Reverses Diabetic Retinopathy in a Mouse Model of Type 2 Diabetes

PDF

Yvonne Adu-Agyeiwaah; Cristiano P. Vieira; Bright Asare-Bediako; Sergio Li Calzi; Mariana DuPont; Jason Floyd; Sanford Boye; Vince Chiodo; Julia V. Busik; Maria B. Grant
TAGS: diabetes mellitus, diabetes mellitus, type 2, diabetic retinopathy, intravitreal injections, mice, retina, blood capillaries, inflammation, hypoxia
Trans. Vis. Sci. Tech.. 2023; 12(4):20. https://doi.org/10.1167/tvst.12.4.20

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2022

Correction of diabetic retinopathy by mitochondrial transfer

Denis A Proshlyakov; Sandra S Hammer; Sergio Li Calzi; Tim Florian Dorweiler; Cristiano P. Vieira; Kiera Fisher; Shari Atilano; M.Cristina Kenney; Julia V Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):791 – F0350.

ARVO Annual Meeting Abstract June 2022

Intravitreal administration of AAV2-SIRT1 reverses diabetic retinopathy (DR) in a murine model of type 2 diabetes (T2D)

Maria B Grant; Yvonne Adu-Agyeiwaah; Cristiano P. Vieira; Bright Asare-Bediako; Sandra S Hammer; Sergio Li Calzi; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2310.

ARVO Annual Meeting Abstract June 2022

DIFFERENTIAL RECUITMENT OF HEMATOPOIETIC CELLS INTO THE INJURED RPE/CHOROID

Bright Asare-Bediako; Sergio Li Calzi; Yvonne Adu-Agyeiwaah; Jason Floyd; Mariana D DuPont; Maria Grant

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3025 – F0396.

ARVO Annual Meeting Abstract June 2022

Oral administration of alpha-cyclodextrin reverses diabetic retinopathy in db/db mice

Yvonne Adu-Agyeiwaah; Sandra S Hammer; Cristiano P. Vieira; Bright Asare-Bediako; Jason Floyd; Mariana D DuPont; Ram Prasad; Sergio Li Calzi; Julia V Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3591 – A0046.

ARVO Annual Meeting Abstract June 2021

Statins and α cyclodextrin treatments prevent cholesterol crystal-induced pathology in human retinal endothelial cells and in db/db mice.

Sandra S Hammer; Delaney McFarland; George Abela; Sergio Li Calzi; Maria B Grant; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2928.

ARVO Annual Meeting Abstract June 2021

Intravitreal AAV2-SIRT1 administration reverses diabetic retinopathy in db/db mice

Yvonne Adu-Agyeiwaah; Cristiano P. Vieira; Bright Asare-Bediako; Sandra S Hammer; Sergio Li Calzi; Julia V Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1106.

ARVO Annual Meeting Abstract June 2020

Oral administration of engineered probiotic prevents gut dysbiosis in type 1 diabetes and alleviates diabetic retinopathy (DR)

Ram Prasad; Jason L. Floyd; DIBYENDU CHAKRABORTY; Bright Asare-Bediako; Yvonne Adu-Agyeiwaah; Sergio Li Calzi; Robert F. Rosencrans; Chao Huang; Mariana DuPont; Sunil K Noothi; Qiuhong Li; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1169.

ARVO Annual Meeting Abstract June 2020

LXR activation prevents development of diabetic retinopathy (DR) in db/db mice by controlling cholesterol and stem cell profiles

Yvonne Adu-Agyeiwaah; Cristiano P Vieira; Ana Leda Longhini; Bright Asare-Bediako; Micheli Sielski; Mariana DuPont; Sergio Li Calzi; Julia Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):5161.

ARVO Annual Meeting Abstract July 2019

Altered Circadian Metabolites in Type 2 Diabetic Mice with Diabetic Retinopathy

Samantha Prabakaran; Eleni Beli; Yaqian Duan; Sergio Li Calzi; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2672.

ARVO Annual Meeting Abstract July 2019

In Vivo Retinal Structural Lesions, Functional Deficits and Peripheral Blood Cell phenotype in Mice with High-Fat Diet-Induced Retinopathy

Bright Asare-Bediako; Sunil Nooti; Sergio Li Calzi; Baskaran Athmanathan; Cristiano Pedrozo Vieira; Ana Leda Figueiredo Longhini; Mariana Dupont; DIBYENDU CHAKRABORTY; Prabhakara R Nagareddy; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2688.

ARVO Annual Meeting Abstract July 2019

A PLGA-Carboxyamidotriazole (CAI) Polymeric Suspension Suppresses Pathological Ocular Angiogenesis in rodent CNV model.

Sergio Li Calzi; DIBYENDU CHAKRABORTY; Bright Asare-Bediako; Isabel Franklin; Srikanth Kakumanu; Laurent Balenci; Maria B Grant; Alan Franklin

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5411.

ARVO Annual Meeting Abstract July 2019

TRIB3 ablation attenuates hypoxia-induced angiogenesis in mouse retinas

Priyamvada M Pitale; Yvonne Adu-Agyeiwaah; Sergio Li Calzi; Takashi Satoh; Shizuo Akira; Maria B Grant; Marina S Gorbatyuk

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6428.

ARVO Annual Meeting Abstract July 2018

Progenitor cell combination normalizes pericyte ensheathment in the oxygen-induced retinopathy (OIR) model

Sergio Li Calzi; Lynn C Shaw; William C Shelley; Judith Quigley; Leni Moldovan; Mircea Ivan; Michael E Boulton; Mervin C Yoder; Maria Grant

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):765.

ARVO Annual Meeting Abstract July 2018

Intermittent Fasting (IF) Prevents Development of Diabetic Retinopathy (DR) by regulating low-grade inflammation through changes in lipid metaobolism

Eleni Beli; Leni Moldovan; Yaqian Duan; Sergio Li Calzi; Carmella Evans-Molina; Julia V Busik; Maria Grant

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):6002.

Retinal Cell Biology February 2018

Enteral Arg-Gln Dipeptide Administration Increases Retinal Docosahexaenoic Acid and Neuroprotectin D1 in a Murine Model of Retinopathy of Prematurity

PDF

Lynn Calvin Shaw; Sergio Li Calzi; Nan Li; Leni Moldovan; Nilanjana Sengupta-Caballero; Judith Lindsey Quigley; Mircea Ivan; Bokkyoo Jun; Nicolas G. Bazan; Michael Edwin Boulton; Julia Busik; Josef Neu; Maria B. Grant
TAGS: dipeptides, mice, neovascularization, pathologic, retinopathy of prematurity, docosahexaenoic acids, retinal injuries
Invest. Ophthalmol. Vis. Sci.. 2018; 59(2):858-869. https://doi.org/10.1167/iovs.17-23034

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

LP-ACE2 attenuates diabetic visual impairment by improving gut barrier integrity and intestinal lymphatics in type 1 diabetes

Human iPSC derived CD34 + cells and endothelial colony-forming cells (ECFCs) correct diabetic retinopathy (DR) in a model of type 2 diabetes

Oral alpha-cyclodextrin reverses cholesterol-crystal-induced retinal pathology in a rodent model of type 2 diabetes (T2D).

Calvarium bone marrow is the source of bone marrow-derived cells that migrate into the injured retina

Intravitreal Administration of AAV2-SIRT1 Reverses Diabetic Retinopathy in a Mouse Model of Type 2 Diabetes

Correction of diabetic retinopathy by mitochondrial transfer

Intravitreal administration of AAV2-SIRT1 reverses diabetic retinopathy (DR) in a murine model of type 2 diabetes (T2D)

DIFFERENTIAL RECUITMENT OF HEMATOPOIETIC CELLS INTO THE INJURED RPE/CHOROID

Oral administration of alpha-cyclodextrin reverses diabetic retinopathy in db/db mice

Statins and α cyclodextrin treatments prevent cholesterol crystal-induced pathology in human retinal endothelial cells and in db/db mice.

Intravitreal AAV2-SIRT1 administration reverses diabetic retinopathy in db/db mice

Oral administration of engineered probiotic prevents gut dysbiosis in type 1 diabetes and alleviates diabetic retinopathy (DR)

LXR activation prevents development of diabetic retinopathy (DR) in db/db mice by controlling cholesterol and stem cell profiles

Altered Circadian Metabolites in Type 2 Diabetic Mice with Diabetic Retinopathy

In Vivo Retinal Structural Lesions, Functional Deficits and Peripheral Blood Cell phenotype in Mice with High-Fat Diet-Induced Retinopathy

A PLGA-Carboxyamidotriazole (CAI) Polymeric Suspension Suppresses Pathological Ocular Angiogenesis in rodent CNV model.

TRIB3 ablation attenuates hypoxia-induced angiogenesis in mouse retinas

Progenitor cell combination normalizes pericyte ensheathment in the oxygen-induced retinopathy (OIR) model

Intermittent Fasting (IF) Prevents Development of Diabetic Retinopathy (DR) by regulating low-grade inflammation through changes in lipid metaobolism

Enteral Arg-Gln Dipeptide Administration Increases Retinal Docosahexaenoic Acid and Neuroprotectin D1 in a Murine Model of Retinopathy of Prematurity

To View More...

You must be signed into an individual account to use this feature.